Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lumentum Holdings Inc.LITE · Entity 2957 | Director | July 15, 2026 | July 17, 2026 |
| ON SEMICONDUCTOR CORPON · Entity 3161 | Exec VP & CFO | April 23, 2026 | April 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lumentum Holdings Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,313 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 108 · Balance 1,313 F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents the contingent right to receive, following vesting, one share of Common Stock of the Issuer. 100% of the RSUs shall vest on July 15, 2027, subject to the Reporting Person continuing through such date as a Service Provider, as defined under the Issuer's 2025 Equity Incentive Plan. The RSUs were granted to the Reporting Person in lieu of the annual cash retainer, at the election of the Reporting Person, under the Issuer's compensation program for non-employee directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents the contingent right to receive, following vesting, one share of Common Stock of the Issuer. 100% of the RSUs shall vest on July 15, 2027, subject to the Reporting Person continuing through such date as a Service Provider, as defined under the Issuer's 2025 Equity Incentive Plan. The RSUs were granted to the Reporting Person in lieu of the annual cash retainer, at the election of the Reporting Person, under the Issuer's compensation program for non-employee directors.
ON SEMICONDUCTOR CORP
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 271,194 |
Ending reported balance
After 2026-04-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-23 · Sale · Disposed 30,000 · Balance 301,194 Row 2 · 2026-04-24 · Sale · Disposed 30,000 · Balance 271,194 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYPRESS SEMICONDUCTOR CORP /DE/
Report date April 16, 2020 · Filed April 17, 2020
Section 16 reporting ended · disclosed 2020-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 1
1 source rowRow 1 · 2020-04-16 · Disposition to issuer · Disposed 350,555 · Balance 0 F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-16 · Disposition to issuer · Disposed 16,737 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3: On February 16, 2018, the Reporting Person was granted 50,210 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-16 · Disposition to issuer · Disposed 40,630 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5: On February 15, 2019, the Reporting Person was granted 70,425 restricted stock units, with approximately 42% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-04-16 · Disposition to issuer · Disposed 86,617 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F6: On March 1, 2020, the Reporting Person was granted 86,617 restricted stock units that vest in three equal annual installments beginning on February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest.
F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement.
F3: On February 16, 2018, the Reporting Person was granted 50,210 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement.
F5: On February 15, 2019, the Reporting Person was granted 70,425 restricted stock units, with approximately 42% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date.
F6: On March 1, 2020, the Reporting Person was granted 86,617 restricted stock units that vest in three equal annual installments beginning on February 14, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2018 Filed Mar 2, 2018 20:13 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016065 · doc4.xml · nonDerivative · entry 5 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the April 1, 2016 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:13 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 10,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016065 · doc4.xml · nonDerivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the May 7, 2015 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:13 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 21,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016065 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 3, 2015 grant awarded under the Issuer's 2013 Stock Plan (the "Stock Plan") as part of the Issuer's Performance Based Accelerated Restricted Stock Program (the "PARS Program"). F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 17:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 50,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-012060 · doc4.xml · derivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,210 Underlying: Common Stock · 50,210 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On February 16, 2018, the Reporting Person was granted 50,210 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 16, 2018, the Reporting Person was granted 50,210 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,660 | $16.60 | $160,396.57 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 6 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,912 Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 3,574 | $16.61 | $59,380.58 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 4 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,572 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.6101 to $16.615 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 7,475 | $16.67 | $124,629.18 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,146 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.67 to $16.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · derivative · entry 9 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F6 · derivative.exercise_date: On April 1, 2016, the Reporting Person was granted 27,000 RSUs, vesting in one annual installment on February 2, 2018. F6 · derivative.expiration_date: On April 1, 2016, the Reporting Person was granted 27,000 RSUs, vesting in one annual installment on February 2, 2018. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · derivative · entry 8 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F5 · derivative.exercise_date: On May 7, 2015, the Reporting Person was granted 30,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. F5 · derivative.expiration_date: On May 7, 2015, the Reporting Person was granted 30,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · derivative · entry 7 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On March 3, 2015, the Reporting Person was granted 60,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. F4 · derivative.expiration_date: On March 3, 2015, the Reporting Person was granted 60,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 5 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 17:30 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007928 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 16:54 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 551 | $16.84 | $9,280.93 |
DisclosureSEC source: 0001209191-17-062101 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,621 F2 · shares: Represents the aggregate number of shares of common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. Read SEC document |
| November 19, 2017 Filed Nov 21, 2017 16:54 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-062101 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On December 18, 2012, the Reporting Person was granted 5,333 restricted stock units, vesting in five equal annual installments beginning on November 19, 2013. F3 · derivative.expiration_date: On December 18, 2012, the Reporting Person was granted 5,333 restricted stock units, vesting in five equal annual installments beginning on November 19, 2013. Read SEC document |
| November 19, 2017 Filed Nov 21, 2017 16:54 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-062101 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 16:41 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 74,818 | $15.77 | $1,180,194.10 |
DisclosureSEC source: 0001209191-17-057306 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,105 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.6900 to $15.8700 per share, inclusive. The Reporting Person undertakes to provide to Cypress Semiconductor Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 10, 2017 Filed Aug 21, 2017 17:13 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049735 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,923 F1 · timeliness: The Reporting Person is voluntarily reporting his gift of shares of Issuer common stock to a charitable organization on Form 4 instead of later reporting on a deferred basis on a year-end Form 5. Because this is a voluntary Form 4, the Reporting Person was not required to file this Form 4 before the end of the second business day following August 10, 2017, and is permitted to report the gift on Form 4 at any time prior to the due date for a Form 5, which is 45 days after December 31, 2017, Issuer's fiscal year-end. F2 · shares: Represents a gift of shares of Issuer common stock to a charitable organization. Read SEC document |
| May 10, 2017 Filed May 10, 2017 19:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 694 | $13.49 | $9,364.77 |
DisclosureSEC source: 0001209191-17-031411 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,475 F2 · shares: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. F2 · price: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. Read SEC document |
| May 09, 2017 Filed May 10, 2017 19:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031411 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,334 Underlying: Common Stock · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On May 30, 2013, the Reporting Person was granted 6,666 restricted stock units, vesting in five equal annual installments beginning on May 9, 2014. F3 · derivative.expiration_date: On May 30, 2013, the Reporting Person was granted 6,666 restricted stock units, vesting in five equal annual installments beginning on May 9, 2014. Read SEC document |
| May 09, 2017 Filed May 10, 2017 19:09 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031411 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 19:35 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 57,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021856 · doc4.xml · derivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,507 Underlying: Common Stock · 57,507 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis. Two-thirds of the RSUs will vest on February 1, 2019 and the remaining one-third will vest on February 3, 2020. F2 · derivative.expiration_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis. Two-thirds of the RSUs will vest on February 1, 2019 and the remaining one-third will vest on February 3, 2020. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 43,349 | $13.30 | $576,741.11 |
DisclosureSEC source: 0001209191-17-017004 · doc4.xml · nonDerivative · entry 4 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,836 F5 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.29 to $13.325 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 21,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017004 · doc4.xml · nonDerivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the April 1, 2016 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 20,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017004 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the May 7, 2015 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 41,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017004 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 3, 2015 grant awarded under the Issuer's 2013 Stock Plan (the "Stock Plan") as part of the Issuer's Performance Based Accelerated Restricted Stock Program (the "PARS Program"). F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 17:47 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 4,020 | $11.74 | $47,206.06 |
DisclosureSEC source: 0001209191-17-007229 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,115 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 17:47 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 9,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007229 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On November 3, 2016, the Reporting Person was granted 9,484 RSUs in lieu of a cash bonus which was payable under existing Issuer incentive programs. This RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and was fully vested on January 31, 2017. F2 · derivative.expiration_date: On November 3, 2016, the Reporting Person was granted 9,484 RSUs in lieu of a cash bonus which was payable under existing Issuer incentive programs. This RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and was fully vested on January 31, 2017. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 17:47 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 9,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007229 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 3,875 | $11.76 | $45,562.64 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · nonDerivative · entry 4 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,651 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.825 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 8,131 | $11.81 | $96,043.37 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,526 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $11.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · derivative · entry 6 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F5 · derivative.exercise_date: On May 7, 2015, the Reporting Person was granted 30,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. F5 · derivative.expiration_date: On May 7, 2015, the Reporting Person was granted 30,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · derivative · entry 5 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: On March 3, 2015, the Reporting Person was granted 60,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. F4 · derivative.expiration_date: On March 3, 2015, the Reporting Person was granted 60,000 RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · nonDerivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006473 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 20:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 10,340 | $11.55 | $119,427.00 |
DisclosureSEC source: 0001209191-17-001602 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,207 Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 20:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001602 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. F2 · derivative.expiration_date: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 20:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-001602 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 552 | $11.03 | $6,090.66 |
DisclosureSEC source: 0001209191-16-151700 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,547 Read SEC document |
| November 19, 2016 Filed Nov 22, 2016 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-151700 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067 Underlying: Common Stock · 1,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 18, 2012, the Reporting Person was awarded a grant of 5,333 RSUs. This equity grant vests annually beginning November 19, 2013. F2 · derivative.expiration_date: On December 18, 2012, the Reporting Person was awarded a grant of 5,333 RSUs. This equity grant vests annually beginning November 19, 2013. Read SEC document |
| November 19, 2016 Filed Nov 22, 2016 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 1,067 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-151700 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 18:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 918 | $10.71 | $9,832.97 |
DisclosureSEC source: 0001209191-16-150671 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,032 Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 18:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 1,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-150671 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,734 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 1, 2011, the Reporting Person was awarded a grant of 8,666 RSUs. This equity grant vested annually beginning November 14, 2012 and is fully vested. F2 · derivative.expiration_date: On December 1, 2011, the Reporting Person was awarded a grant of 8,666 RSUs. This equity grant vested annually beginning November 14, 2012 and is fully vested. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 18:10 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 1,734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-150671 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 19:00 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 9,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148737 · doc4.xml · derivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,484 Underlying: Common Stock · 9,484 shares Expires not disclosed F1 · security: The Reporting Person was awarded an equity grant of Restricted Stock Units ("RSUs") in lieu of a cash bonus which was payable under existing Issuer incentive programs. The RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. F2 · derivative.exercise_price: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting of the RSUs. F2 · price: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting of the RSUs. F3 · derivative.exercise_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. F3 · derivative.expiration_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 16:41 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,450 | $0.00 Strike: $3.99 | $0.00 |
DisclosureSEC source: 0001209191-16-145700 · doc4.xml · derivative · entry 3 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,450 shares Expires 2016-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · kind: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F1 · shares: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F1 · derivative.exercise_date: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.exercise_date: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F1 · derivative.expiration_date: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.expiration_date: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 16:41 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | SaleCommon Stock | 11,390 | $11.83 | $134,764.20 |
DisclosureSEC source: 0001209191-16-145700 · doc4.xml · nonDerivative · entry 2 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,216 F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · kind: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F3 · kind: Shares of Issuer common stock were sold for payment of the exercise price and tax liability incident to the exercise and subsequent sale of shares acquired pursuant to the exercise of the option. F1 · shares: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F3 · shares: Shares of Issuer common stock were sold for payment of the exercise price and tax liability incident to the exercise and subsequent sale of shares acquired pursuant to the exercise of the option. F4 · price: Represents a weighted average sales price per share. These shares were purchased in multiple transactions at prices ranging from $11.81 to $11.85 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 16:41 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 15,450 | $3.99 | $61,609.97 |
DisclosureSEC source: 0001209191-16-145700 · doc4.xml · nonDerivative · entry 1 Thad Trent · CIK 0001607990 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · kind: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. F1 · shares: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: This option was due to expire on October 27, 2016. The option was awarded to the Reporting Person on October 27, 2006 and was fully vested on October 1, 2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.